ATP1A3 and Alzheimer disease: Furthermore, single particleanalysis of plasma from patients with Alzheimer's disease indicateshigher amyloid-β positivity in ATP1A3+ EVs, suggestingthey provide better diagnostic prediction than that of other plasmabiomarkers.